WaVe Life Sciences
2010
FOUNDED
PUBLIC
STATUS
201-300
EMPLOYEES
WVE
STOCK SYMBOL
$21.34
SHARE PRICE
(As of Friday Closing)
Description
WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.
Website
Formerly Known As
Ontorii
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
- 733 Concord Avenue
- Cambridge, MA 02138
- United States
+1 (617) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore WaVe Life Sciences’s full profile, request a free trial.
WaVe Life Sciences Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $18.16 - $56.00 | $732M | $21.77 | -$5.14 | 255K | 34.3M |
WaVe Life Sciences Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 648,971 | 1,036,040 | 822,745 | 452,836 |
| Revenue | 18,767 | 14,414 | 3,893 | 1,092 |
| EBITDA | (154,208) | (141,025) | (98,989) | (54,731) |
| Net Income | (161,660) | (146,653) | (101,980) | (55,660) |
| Total Assets | 385,547 | 295,940 | 181,843 | 164,811 |
| Total Debt | 34,009 | 10,403 | 3,454 | 78 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
WaVe Life Sciences Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore WaVe Life Sciences‘s full profile, request access.
Request full access to PitchBookWaVe Life Sciences Competitors (42)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Homology Medicines | Formerly VC-backed | Bedford, MA | 000 | 00000 | 00000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Richmond, CA | 000 | 000.00 | 00000000 | 000.00 |
| 000000000 00000000 | Formerly VC-backed | Zurich, Switzerland | 000 | 00000 | 00000000000 | 00000 |
| 00000000 000000000 | Formerly VC-backed | San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
| 000000000 00000000 | Formerly VC-backed | San Diego, CA | 00 | 00000 | 00000000 | 00000 |
WaVe Life Sciences Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore WaVe Life Sciences‘s full profile, request access.
Request full access to PitchBookWaVe Life Sciences Executive Team (6)
1 Former Executive
You’re viewing 5 of 6 executives. Get the full list »WaVe Life Sciences Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Adrian Rawcliffe | Self | Board Member | 000 0000 | |
| Christian Henry | Self | Chairman & Board Member | 000 0000 | |
| Gregory Verdine Ph.D | WaVe Life Sciences | Board Member & Founder | 000 0000 | |
| Ken Takanashi | Self | Board Member | 000 0000 | |
| Koji Miura | Self | Board Member | 000 0000 |